drugset / Trial / NCT00224770

Minimally Invasive Surgery and rtPA for Intracerebral Hemorrhage Evacuation

NCT00224770

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this trial is to determine the safety of using a combination of minimally invasive surgery and clot lysis with rt-PA to remove intracerebral hemorrhage (ICH). The ICES arm of the trial will determine the safety of endoscopic surgery to remove ICH. All MISTIE intention to treat subjects represent the hypothesized test group. The ICES cohort is to be analyzed separately.

Timeline

Start
2005-08
Primary completion
2012-08
Completion
2013-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Alteplase Protein / enzyme biologic 0.3 mg Other
Comparator Alteplase Protein / enzyme biologic 1 mg Other